Downstream Toll-like receptor signaling mediates adaptor-specific cytokine expression following focal cerebral ischemia.

J Neuroinflammation 2012 Jul 16;9:174. Epub 2012 Jul 16.

Stroke Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, 10 Center Drive, Building 10, Room 5B06, MSC 1401, Bethesda, MD 20892-1401, USA.

Background: Deletion of some Toll-like receptors (TLRs) affords protection against cerebral ischemia, but disruption of their known major downstream adaptors does not. To determine whether compensation in the production of downstream effectors by one pathway when the other is disrupted can explain these findings, we examined cytokine/chemokine expression and inflammatory infiltrates in wild-type (WT), MyD88(-/-) and TRIF-mutant mice following permanent middle cerebral artery occlusion (pMCAO).

Methods: Cytokine/chemokine expression was measured with a 25-plex bead array in the serum and brains of all three groups of mice at baseline (no surgery/naïve) and at 3 hours and 24 hours following pMCAO. Brain inflammatory and neutrophil infiltrates were examined 24 hours following pMCAO.

Results: IL-6, keratinocyte chemoattractant (KC), granulocyte colony-stimulating factor (G-CSF) and IL-10 were significantly decreased in MyD88(-/-) mice compared to WT mice following pMCAO. Significantly, decreased levels of the neutrophil chemoattractants KC and G-CSF corresponded with a trend toward fewer neutrophils in the brains of MyD88(-/-) mice. IP-10 was significantly decreased when either pathway was disrupted. MIP-1 α was significantly decreased in TRIF-mutant mice, consistent with TRIF-dependent production. MyD88(-/-) mice showed elevations of a number of Th2 cytokines, such as IL-13, at baseline, which became significantly decreased following pMCAO.

Conclusions: Both MyD88 and TRIF mediate pathway-specific cytokine production following focal cerebral ischemia. Our results also suggest a compensatory Th2-type skew at baseline in MyD88(-/-) mice and a paradoxical switch to a Th1 phenotype following focal cerebral ischemia. The MyD88 pathway directs the expression of neutrophil chemoattractants following cerebral ischemia.

Download full-text PDF

Source
http://dx.doi.org/10.1186/1742-2094-9-174DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3419098PMC
July 2012
3 Reads

Publication Analysis

Top Keywords

cerebral ischemia
20
myd88-/- mice
16
focal cerebral
12
neutrophil chemoattractants
8
trif-mutant mice
8
cytokine/chemokine expression
8
pathway disrupted
8
mice
8
cerebral
6
ischemia
5
decreased
5
myd88-/-
5
brains three
4
mice compared
4
compared mice
4
decreased myd88-/-
4
three groups
4
g-csf il-10
4
3 hours 24 hours
4
il-10 decreased
4

References

(Supplied by CrossRef)

K Takeda et al.
Semin Immunol 2004

TV Arumugam et al.
Shock 2009

YC Wang et al.
J Neuroinflammation 2011

P Matzinger et al.
Science 2002

R Medzhitov et al.
Nat Rev 2001

JR Caso et al.
Circulation 2007

G Ziegler et al.
Biochem Biophys Res Commun 2007

SC Tang et al.
Proc Natl Acad Sci U S A 2007

BM Famakin et al.
Brain Res 2011

A Tsung et al.
Am J Physiol Gastrointest Liver Physiol 2006

F Hua et al.
Biochem Biophys Res Commun 2005

Similar Publications